IL2 and bladder transitional cell carcinoma: For example, FOXQ1 expression inhibited activation of the IL6/JAK/STAT3 signaling pathway, IL2/STAT5 signaling pathway, allograft rejection pathway, apical junction pathway, and complement pathway in bladder urothelial carcinoma (Figure 7A).